This inventor holds 23 USPTO granted patents and 4 published patent applications and 13 EPO patents. Top assignees: Merck Patent Gmbh, Merck Patent Gesellschaft MIT Beschrankter Haftung. Active years: 2005-2018.
Location History:
- Suessel-Fassendorf, DE (2010)
- Wantorf, DE (2008 - 2012)
- Schmilau, DE (2010 - 2016)
- Wentorf, DE (2005 - 2017)
- Suesel-Fassendorf, DE (2011 - 2017)
- Suesel-Fassenberg, DE (2015 - 2018)
Company Filing History:
21 out of 3,020 
2 out of 1,248 
Years Active: 2005-2018
Title: Innovations and Contributions of Oliver Cromwell
Introduction
Oliver Cromwell, based in Suesel-Fassendorf, Germany, is a distinguished inventor known for his significant contributions to biotechnology, particularly in the realm of allergen research. With a total of 23 patents to his name, Cromwell has dedicated his career to improving the understanding and treatment of pollen allergies, showcasing his innovative spirit and commitment to public health.
Latest Patents
Among his notable patents, two stand out as pivotal advancements in allergy research. The first is related to "Variants of group 5 allergens of the true grasses having reduced allergenicity due to mutagenesis of proline residues." This invention focuses on the development of recombinant variants of group 5 allergens from the Poaceae family, which demonstrate a reduction in IgE reactivity while maintaining essential T-lymphocyte reactivity.
The second significant patent involves the "DNA sequence, and recombinant preparation of the grass pollen allergen Lol p 4." This invention encompasses the provision of a DNA sequence for the major grass pollen allergen Lol p 4, including its fragments and new combinations of partial sequences that exhibit hypoallergenic properties. The recombinant DNA molecules derived from this research are instrumental for both the diagnosis and treatment of pollen allergies.
Career Highlights
Oliver Cromwell's professional journey has been marked by his association with prominent organizations in the biotechnology sector. He worked with Merck Patent GmbH and Merck Patent Gesellschaft mit beschränkter Haftung, where he honed his skills in research and patent development. His experience in these notable companies has been pivotal in shaping his career and contributions to the field.
Collaborations
Throughout his career, Cromwell has collaborated with several esteemed professionals, including Helmut Fiebig and Andreas Nandy. These partnerships have enriched his research and innovation efforts, fostering an environment of collaboration that has led to remarkable advancements in allergy treatment.
Conclusion
Oliver Cromwell represents a paradigm of innovation in the field of biotechnology, with his impactful patents addressing crucial health challenges related to allergies. His dedication to research and collaboration within the industry continues to pave the way for advancements that will benefit countless individuals suffering from pollen allergies.